Concepedia

T.W. Kim

TK

Statistics

Publications

1

Citations

13

H-Index

1

Active since

2022

Affiliations

Imperial College Healthcare NHS Trust(Current)

T.W. Kim is an author at Imperial College Healthcare NHS Trust specializing in systemic therapy for gastrointestinal cancers, toxicity risk assessment, and pharmacology.

Publications per year

2022–2022

1

Publications

1

LBA26 BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC)

Josep Tabernero, T. Yoshino, T.W. Kim et al. · Annals of Oncology · 2022 · 13 citations

, , +11

1–1 of 1